Trial Profile
A Phase 3, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Tazarotene/ulobetasol (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions
- 27 Nov 2015 New trial record